A Randomized, Actively Controlled, Crossover Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Patients With Type II Diabetes
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aspirin/phosphatidylcholine (Primary) ; Aspirin
- Indications Myocardial infarction; NSAID-induced ulcer; Thrombosis
- Focus Pharmacodynamics
- 14 Mar 2016 Biomarkers information updated
- 29 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jan 2012 New trial record